Loizos, Nick External Entity

Publications

Sort by

Selected publications

  • Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors.  Investigational new drugs. 2017 In Process GET IT

Other